Sarah A Buchan, Chi Yon Seo, Caitlin Johnson, Sarah Alley, Jeffrey C Kwong, Sharifa Nasreen, Andrew Calzavara, Diane Lu, Tara M Harris, Kelly Yu, Sarah E Wilson
IMPORTANCE: Increased rates of myocarditis or pericarditis following receipt of COVID-19 mRNA vaccines have been observed. However, few available data are associated with differences in rates of myocarditis or pericarditis specific to vaccine products, which may have important implications for vaccination programs. OBJECTIVE: To estimate rates of reported myocarditis or pericarditis following receipt of a COVID-19 mRNA vaccine by product, age, sex, dose number, and interdose interval...
June 1, 2022: JAMA Network Open